You are here
Drugmakers court fight underscores high stakes in haemophilia
ROCHE'S bid to muscle in on Shire's share of the US$11 billion haemophilia drug market took a new, contentious turn this weekend when the British drugmaker won a court injunction against how the Swiss drugmaker talks about its new medicine.
Shire's injunction on Sunday in a
CALL +65 6388 3838 EMAIL email@example.com